We are live on ! Find out more
SC

Searle & Co Portfolio holdings

AUM $445M
1-Year Est. Return 41.72%
This Fund
S&P 500
This Quarter Est. Return
-0.26%
1 Year Est. Return
+41.72%
3 Year Est. Return
+93.84%
5 Year Est. Return
+130.57%
10 Year Est. Return
+365.42%
AUM
$244M
AUM Growth
-$354K
Cap. Flow
+$1.72M
Cap. Flow %
0.7%
Top 10 Hldgs %
29.67%
Holding
153
New
6
Increased
11
Reduced
10
Closed
5

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$732K
2
IFF icon
International Flavors & Fragrances
IFF
+$608K
3
CLX icon
Clorox
CLX
+$456K
4
INCY icon
Incyte
INCY
+$429K
5
NEM icon
Newmont
NEM
+$412K

Sector Composition

Rank Sector Weight
1 Healthcare 20%
2 Technology 18.47%
3 Industrials 13.22%
4 Financials 10.92%
5 Consumer Discretionary 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
26
Procter & Gamble
PG
$336B
$3.1M 1.27%
22,204
+100
+0.5% +$14.2K
UPS icon
27
United Parcel Service
UPS
$88.6B
$2.96M 1.21%
16,250
QQQ icon
28
Invesco QQQ Trust
QQQ
$453B
$2.92M 1.19%
8,150
BAX icon
29
Baxter International
BAX
$13.5B
$2.91M 1.19%
36,234
ADP icon
30
Automatic Data Processing
ADP
$106B
$2.88M 1.18%
14,412
CSCO icon
31
Cisco
CSCO
$457B
$2.87M 1.18%
52,810
DHR icon
32
Danaher
DHR
$137B
$2.68M 1.1%
9,929
+113
+1% +$30.8K
DEO icon
33
Diageo
DEO
$49B
$2.62M 1.07%
13,583
MRK icon
34
Merck
MRK
$322B
$2.6M 1.06%
34,606
+9,621
+39% +$732K
YUMC icon
35
Yum China
YUMC
$16.5B
$2.56M 1.05%
44,100
HZNP
36
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.46M 1.01%
22,500
NKE icon
37
Nike
NKE
$61.9B
$2.45M 1%
16,850
-500
-3% -$81.5K
BA icon
38
Boeing
BA
$171B
$2.32M 0.95%
10,535
NOC icon
39
Northrop Grumman
NOC
$77.1B
$2.31M 0.95%
6,418
CVS icon
40
CVS Health
CVS
$133B
$2.29M 0.94%
26,980
QCOM icon
41
Qualcomm
QCOM
$155B
$2.28M 0.93%
17,650
SWK icon
42
Stanley Black & Decker
SWK
$14.3B
$2.18M 0.89%
12,460
AZN icon
43
AstraZeneca
AZN
$263B
$2.14M 0.88%
17,800
T icon
44
AT&T
T
$159B
$2.04M 0.83%
99,848
SPY icon
45
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$2.02M 0.83%
4,700
ABT icon
46
Abbott
ABT
$183B
$2M 0.82%
16,900
IRM icon
47
Iron Mountain
IRM
$36.4B
$1.96M 0.8%
45,200
HES
48
DELISTED
Hess
HES
$1.93M 0.79%
24,750
BRK.B icon
49
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.87M 0.76%
6,840
AMZN icon
50
Amazon
AMZN
$2.92T
$1.87M 0.76%
11,360

Similar funds

Searle & Co's Q3 2021 Portfolio in Review

As of Q3 2021, Searle & Co held 153 positions worth $244M, down 0.14% from $245M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Searle & Co's Q3 2021 filing shows 6 new, 11 increased, 10 reduced and 5 closed positions. Its largest new stake was Clorox: 2,646 shares worth $438K. The largest sale was W.R. Grace & Co., an estimated $1.08M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

  • Searle & Co's largest Q3 2021 buy was Clorox: 2,646 shares worth $438K.
  • Searle & Co added most to Merck in Q3 2021, an estimated $732K increase.
  • Searle & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $221K.
  • Searle & Co fully exited W.R. Grace & Co. in Q3 2021, selling an estimated $1.08M.
  • Searle & Co's ten largest holdings make up 30% of its $244M portfolio in Q3 2021.
  • Searle & Co opened 6 new positions and closed 5 in Q3 2021.
  • Searle & Co's portfolio value fell 0.14% quarter-over-quarter to $244M.

Based on Searle & Co's 13F filing for Q3 2021, filed 8 Oct 2021.